You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Duchenne Tamoxifen

Showing 1 - 25 of 673
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Duchenne Muscular Dystrophy Trial (Tamoxifen)

Completed
  • Duchenne Muscular Dystrophy
  • (no location specified)
Jul 21, 2022

Duchenne Muscular Dystrophy Trial in Worldwide (Tamoxifen, Matching )

Completed
  • Duchenne Muscular Dystrophy
  • Garches, France
  • +10 more
Dec 19, 2022

Duchenne Muscular Dystrophy Video Assessment Registry

Recruiting
  • Duchenne Muscular Dystrophy
    • Plymouth, Massachusetts
      Casimir
    Feb 1, 2023

    Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +3 more
    • Method(s)1 Attribution
    • Method(s)2 Attribution,
    • Colorado Springs, Colorado
      PNAF Medical
    Nov 23, 2023

    CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

    Recruiting
    • Breast Cancer
    • +2 more
      • Erlangen, Germany
        Department of Gynecology and Obstetrics, Erlangen University Hos
      May 12, 2023

      Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

      Active, not recruiting
      Has Results
      • Estrogen Receptor Positive Breast Cancer
      • +7 more
      • Birmingham, Alabama
      • +499 more
      Nov 15, 2022

      Peabody Developmental Motor Scaling In Period Duchenne Muscular

      Completed
      • Duchenne Muscular Dystrophy (DMD)
      • Peabody Developmental Motor Scales-2, PDMS
      • Samsun, Turkey
        Ondokuz Mayıs University
      Aug 6, 2023

      Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

      Not yet recruiting
      • Breast Atypical Hyperplasia
      • +3 more
      • Acolbifene Hydrochloride
      • +4 more
      • Duarte, California
      • +3 more
      Jul 11, 2023

      Duchenne Muscular Dystrophy Trial (Designed Physical Therapy Program, Bicycle Ergometry Training)

      Not yet recruiting
      • Duchenne Muscular Dystrophy
      • Designed Physical Therapy Program
      • Bicycle Ergometry Training
      • (no location specified)
      May 5, 2023

      Duchenne Muscular Dystrophy Trial in Los Angeles, Columbus (SGT-003)

      Not yet recruiting
      • Duchenne Muscular Dystrophy
      • SGT-003
      • Los Angeles, California
      • +1 more
      Nov 14, 2023

      Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

      Recruiting
      • Duchenne Muscular Dystrophy
      • Phase 1, SQY51
      • +3 more
      • Garches, France
        Hôpital Raymond Poincaré
      Mar 7, 2023

      Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)

      Active, not recruiting
      Has Results
      • Breast Cancer
      • Burbank, California
      • +227 more
      Nov 15, 2022

      Duchenne Muscular Dystrophy Trial in Chengdu (JWK007 Single intravenous infusion administration)

      Recruiting
      • Duchenne Muscular Dystrophy
      • JWK007 Single intravenous infusion administration
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 29, 2023

      Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

      Active, not recruiting
      • Neuroendocrine Tumors
      • +2 more
      • Tampa, Florida
      • +1 more
      Jan 13, 2023

      AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys

      Recruiting
      • Duchenne Muscular Dystrophy
      • AAV8 DetectCDx
      • Atlanta, Georgia
        Rare Disease Research
      Jan 12, 2023

      NSAA NON-Interventional Study Protocol

      Not yet recruiting
      • Duchenne Muscular Dystrophy
      • Remote Administration of NSAA
      • (no location specified)
      Sep 19, 2023

      Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

      Active, not recruiting
      Has Results
      • Invasive Breast Carcinoma
      • +3 more
      • Bevacizumab
      • +4 more
      • Mobile, Alabama
      • +525 more
      Jan 28, 2023

      Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

      Recruiting
      • Atypical Hyperplasia
      • Lobular Carcinoma in Situ
      • Evanston, Illinois
      • +1 more
      Jan 20, 2023

      Duchenne Muscular Dystrophy Trial in United States (EDG-5506 Dose 1, EDG-5506 Dose 2, Placebo)

      Not yet recruiting
      • Duchenne Muscular Dystrophy
      • EDG-5506 Dose 1
      • +2 more
      • Los Angeles, California
      • +6 more
      Oct 26, 2023

      Duchenne Muscular Dystrophy and Its Effects on Motor Functions

      Active, not recruiting
      • Duchenne Muscular Dystrophy
      • Modified Mini Mental Test:
      • +10 more
      • Ankara, Turkey
        Hacettepe University, Faculty of Physical Therapy and Rehabilita
      Dec 18, 2022

      Estrogen-receptor Positive Premenopausal Early Breast Cancer

      Active, not recruiting
      • Early Breast Cancer
      • None intervention (observational study)
      • Aviano, Italy
      • +39 more
      Feb 7, 2023

      Breast Cancer Trial in London (Tamoxifen Citrate 20Mg Tab, Placebo)

      Active, not recruiting
      • Breast Cancer
      • Tamoxifen Citrate 20Mg Tab
      • Placebo
      • London, England, United Kingdom
        Queen Mary University of London
      Jan 13, 2023

      Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

      Recruiting
      • Premenopausal Breast Cancer
      • Hormone Receptor-positive Breast Cancer
      • Tamoxifen Oral Product
      • +2 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 14, 2022

      Duchenne Muscular Dystrophy Trial (PGN-EDO51)

      Not yet recruiting
      • Duchenne Muscular Dystrophy
      • (no location specified)
      Oct 5, 2023

      Duchenne Muscular Dystrophy Trial in Little Rock (RGX-202)

      Recruiting
      • Duchenne Muscular Dystrophy
      • RGX-202
      • Little Rock, Arkansas
        Arkansas Children's Hospital
      Jan 12, 2023